Synchrony Financial (NYSE:SYF) Q4 2023 Earnings Call Transcript

Ryan Nash: Brian, maybe as a follow-up to the first question. I just wanted to flush out the NII and NIM guide a little bit more. Can you maybe just talk about, one, what gets us to the bottom end of the range to the top of the range, obviously, it’s a pretty wide range and maybe just explain a little bit further, what is the 30% beta? Is that a point-to-point? Is that a downside? I just want to make sure we fully understand that. And lastly, just given that you are liability-sensitive on the way up, do you still see a path to a 16% NIM and over what timeframe? Thanks.

Brian Wenzel: Yeah. Thanks for the question, Ryan. So let me deal with the beta comment first. So, when you think about beta, this is really the beta in year for really effectively the end of the year. I think, if you think about betas over a longer period of time, so think about what you would see in any rate declined cycle here. I would not expect a beta one, we didn’t get one on the way up. So, we wouldn’t get one on the way down. When you look at our book of — our portfolio of liabilities, we were approximately 80% beta on savings, 90% beta on CDs. I would expect that over that cycle coming down. So, over time, you’re going to see it kind of probably mirror the way it went up, it will mirror on the way down. So, that’s how I would think about betas over the over the longer-term.

When you think about the net interest income, the question here becomes, what is the assumption? If you go — we have three rate cuts in and the market has six, some have as early as March. So, most certainly, if interest-bearing liabilities starts earlier and there is greater rate declines, that could push your NII dollars up. Conversely, if rates don’t get cut off, it could push you a little bit lower. And the big other factor that’s going to come through here is going to be what this payment rate continue to do. We have been conservative, I think on payment rate, saying it doesn’t get back to pre-pandemic levels. I think it’s been slower than our anticipated decline here in 2023. So those are generally the moving pieces as I think how you slide between a range of $17.5 billion to $18.5 billion.

Ryan Nash: Got it. And maybe as a follow-up on credit, you talked about starting to see delinquencies follow more normal patterns and also [charge-offs] (ph) speaking by the second-quarter. Brian, if your outlook proves to be correct, when do we start to see the allowance coming down? When does it peak and come down? And maybe just help us understand the potential magnitude that it could come down over the course of the year. Thank you.

Brian Wenzel: Yeah. So we’re entering the year at 10.26% on a coverage rate basis. I would expect in the first quarter, you’re going to see a rise in normally seasonally rises, receivables go down, number 1. Number 2 is [Technical Difficulty] of just under $200 million, around $200 million for the Ally Lending portfolio that we bring over. There will be some on the purchase accounting marks that will increase that coverage rate a little bit as well it doesn’t go through the P&L. So you’re going to see a rise really in the first-quarter, call it, seasonally. We anticipate that it will be lower than 10.26% as we exit out of [2024] (ph). So you’re primarily going to see growth builds as we move throughout the year, but you will see rate declines.

Some of the QAs burn-off or get realized. And again, if credit performs as we think it would, you’d be exiting down towards the day-one, we won’t be at day-one most certainly in 2024, but trending downwards as we move through the year.

Ryan Nash: Thanks for the color, Brian.

Brian Wenzel: Thanks, Ryan.

Operator: Our next question comes from Moshe Orenbuch with TD Cowen. Please go ahead.

Moshe Orenbuch: Great, thanks. I know that your guidance doesn’t contemplate the late fee ruling yet because it hasn’t been issued, but maybe could you — you did mention that you spent $7 billion kind of in preparation. Could you talk about the things that you are doing in preparation and kind of any updated thoughts you have on the fact, that we’re sitting here kind of in that towards the end of January and haven’t heard anything yet from the CFPB?

Brian Doubles: Yeah, sure, Moshe. I’ll start on this. We’re obviously still waiting for the final rule to be issued, but with that said, while there still some unknowns in terms of the implementation period and other things that we’ll see in the final rule, we’ve been working on this for almost a full-year now at this point. It’s very complicated. Our teams have done a lot of work in preparation for this. We spent a lot of time with our partners. We’ve agreed on pricing actions and offsets that we would deploy when we see the final rule. So it’s really all the work that has been going on over the past year. I mean it’s systems work. You’ve got to issue a lot of CITs, change in terms. And so it’s really that kind of stuff. I will say that the conversations with our partners have been very constructive.

They fully recognize that without these offsets, that a meaningful portion of their customers that we approve today and that we underwrite and give credit to would no longer have access to credit. And that’s something clearly we do not want, they do not want. So really no change to what we said in the past. Our goal is to protect our partners, fully offset the impact of the final rule when it does come. And we want to continue to provide credit to the customers that we do today.

Moshe Orenbuch: Great, thanks. And just as a kind of as a second thought, when you look at the different kind of verticals, obviously you had strong growth in 2023, and a couple of them in Home & Auto had been somewhat weaker, particularly as you got closer to year end. As you look into 2024, any changes in mix in terms of the growth, anything that you’re seeing for launches and product refreshes that are going to drive in those various lines?

Brian Doubles: Yeah, I think, look, generally we would continue to expect outsized growth in Health & Wellness. That’s a platform where we’ve accelerated investment in the past year or two. We’re seeing really good growth from our acquisition of Allegro Credit. It’s a big market. We’ve got a leading position. This is dental, vet, cosmetic, great engagement with partner network. And so that’s a platform we’ll continue to invest in, and we would expect to see growth there on the higher side relative to the other platforms. The other one I would mention is digital. That’s where we’ve got Venmo, Verizon, PayPal, Amazon, and so I think you’d continue to see some outsized growth there. And then maybe a little bit softer in lifestyle and home and auto. I don’t know, Brian, if you’d add anything to that.